Heart Failure Care in China

Advanced heart failure is a trajectory, not a single ejection-fraction value

Patients may have persistent severe symptoms, repeated congestion, low blood pressure, kidney or liver dysfunction, intolerance of medicines, arrhythmias or frequent admissions despite standard treatment.

Specialist review seeks reversible triggers and determines whether advanced therapies are appropriate before frailty or organ damage becomes prohibitive.

Who may be considered?

Specialist review may help when the diagnosis, symptoms and previous treatment create a focused question about advanced heart failure assessment.

• Repeated heart-failure admissions or escalating diuretic need.
• Low output, hypotension or end-organ dysfunction limiting therapy.
• Dependence on intravenous inotropes or recurrent dangerous arrhythmia.
• A question about LVAD, transplant or palliative goals.

What the specialist team must confirm

Review includes the diagnosis and cause, serial echo or MRI, right-heart hemodynamics when indicated, coronary and valve status, rhythm and devices, medication tolerance, kidney and liver function, frailty, nutrition, exercise capacity, support and goals.

From repeated decompensation to a durable care strategy

Advanced options are considered alongside realistic prognosis, burdens and the patient’s values.

Daily management and rapid response prevent avoidable decline

Weight, symptoms, blood pressure, kidney function and medicines are reviewed frequently after decompensation or treatment changes.

Rehabilitation, nutrition, vaccination, caregiver education and a clear plan for worsening symptoms support continuity across countries.

Risks, limits and realistic expectations

Advanced therapies carry major procedural, bleeding, infection, stroke and lifelong-care burdens and may not be appropriate when organ dysfunction or frailty is irreversible. Heart failure can progress despite optimal care.